Resection of colorectal liver metastases: current perspectives (Q36409950)

14 August 2017

1 reference

title

Resection of colorectal liver metastases: current perspectives (English)

1 reference

14 August 2017

James M McLoughlin

1

1 reference

14 August 2017

Eric H Jensen

series ordinal

2

1 reference

14 August 2017

Mokenge Malafa

series ordinal

3

1 reference

14 August 2017

publication date

1 January 2006

1 reference

14 August 2017

1 reference

14 August 2017

volume

13

1 reference

14 August 2017

issue

1

1 reference

14 August 2017

page(s)

32-41

1 reference

Trends in the leading causes of death in the United States, 1970-2002.

14 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1177/107327480601300105

21 January 2018

Cancer statistics, 2005

1 reference

https://api.crossref.org/works/10.1177/107327480601300105

Surgical Treatment of Hepatic Metastases From Colorectal Cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/107327480601300105

Phase I/II study of hepatic arterial therapy with floxuridine and dexamethasone in combination with intravenous irinotecan as adjuvant treatment after resection of hepatic metastases from colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/107327480601300105

Surgical therapy for metastatic disease to the liver

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/107327480601300105

Survival after liver resection for secondary tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/107327480601300105

The natural history of hepatic metastases from colorectal cancer. A comparison with resective treatment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/107327480601300105

Resection of hepatic metastases from colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/107327480601300105

Hepatic metastases from colorectal carcinoma: impact of surgical resection on the natural history

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/107327480601300105

Hepatic resection for metastatic colorectal cancer results in cure for some patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/107327480601300105

Clinical score for predicting recurrence after hepatic resection for metastatic colorectal cancer: analysis of 1001 consecutive cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/107327480601300105

Trends in long-term survival following liver resection for hepatic colorectal metastases

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/107327480601300105

Recurrence and outcomes following hepatic resection, radiofrequency ablation, and combined resection/ablation for colorectal liver metastases

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/107327480601300105

A multifactorial analysis of prognostic factors in patients with liver metastases from colorectal carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/107327480601300105

Factors influencing the natural history of colorectal liver metastases

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/107327480601300105

Resection of colorectal liver metastases

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/107327480601300105

Neoadjuvant chemotherapy before liver resection for patients with unresectable liver metastases from colorectal carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/107327480601300105

A randomized controlled trial of fluorouracil plus leucovorin, irinotecan, and oxaliplatin combinations in patients with previously untreated metastatic colorectal cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/107327480601300105

FOLFIRI followed by FOLFOX6 or the reverse sequence in advanced colorectal cancer: a randomized GERCOR study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/107327480601300105

Early evaluation of combined fluorouracil and leucovorin as a radiation enhancer for locally unresectable, residual, or recurrent gastrointestinal carcinoma. The North Central Cancer Treatment Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/107327480601300105

Surgical management of patients with primary operable colorectal cancer and synchronous liver metastases

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/107327480601300105

Colorectal hepatic metastases: resection, local ablation, and hepatic artery infusion pump are associated with prolonged survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/107327480601300105

Repeat hepatic resection as effective treatment of recurrent colorectal liver metastases

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/107327480601300105

Survival benefit of repeat liver resections for recurrent colorectal metastases: 143 cases. Association Francaise de Chirurgie

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/107327480601300105

Repeat liver resection for recurrent colorectal metastases

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/107327480601300105

Repeated hepatic resection for recurrent metastases from colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/107327480601300105

Second liver resections are safe and effective treatment for recurrent hepatic metastases from colorectal cancer: a bi-institutional analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/107327480601300105

Repeat hepatectomy for colorectal liver metastases

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/107327480601300105

Repeat liver resection for recurrent colorectal liver metastases

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/107327480601300105

Resection of the liver for colorectal carcinoma metastases. A multi-institutional study of long-term survivors

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/107327480601300105

Resection of liver metastases from colorectal cancer--how can we improve results?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/107327480601300105

Morbidity and mortality after hepatic resection of metastases from colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/107327480601300105

"My word, what is that?": Hounsfield and the triumph of clinical research

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/107327480601300105

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/107327480601300105

Comparison of unenhanced and contrast-enhanced spiral CT for assessing interval change in patients with colorectal liver metastases

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/107327480601300105

CT imaging of intrabiliary growth of colorectal liver metastases: a comparison of pathological findings of resected specimens.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/107327480601300105

Imaging of the hepatobiliary tract

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/107327480601300105

MR imaging of liver tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/107327480601300105

Comparison of MR and PET imaging for the evaluation of liver metastases

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/107327480601300105

Prospective evaluation of the impact of [18F]fluoro-2-deoxy-D-glucose positron emission tomography of resectable colorectal liver metastases

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/107327480601300105

Correlating computed tomography and positron emission tomography scan with operative findings in metastatic colorectal cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/107327480601300105

Selection of patients for resection of hepatic metastases: improved detection of extrahepatic disease with FDG pet.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/107327480601300105

Determinants of survival in liver resection for colorectal secondaries

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/107327480601300105

Hepatic resections for bilobar liver metastases from colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/107327480601300105

Global cancer statistics, 2002

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/107327480601300105

Cancer incidence and mortality in Europe, 2004

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/107327480601300105

Treatment of liver metastases, an update on the possibilities and results

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/107327480601300105

Simultaneous liver and colorectal resections are safe for synchronous colorectal liver metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/107327480601300105

Surgical strategies for colorectal liver metastases

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/107327480601300105

OncoSurge: a strategy for improving resectability with curative intent in metastatic colorectal cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/107327480601300105

Treatment of colorectal metastases: surgery, cryotherapy, or radiofrequency ablation

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/107327480601300105

Hepatic arterial infusion of chemotherapy after resection of hepatic metastases from colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/107327480601300105

Impact of surgery on survival in palliative patients with metastatic colorectal cancer after first line treatment with weekly 24-hour infusion of high-dose 5-fluorouracil and folinic acid

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/107327480601300105

Tumor progression while on chemotherapy: a contraindication to liver resection for multiple colorectal metastases?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/107327480601300105

Neoadjuvant treatment of unresectable liver disease with irinotecan and 5-fluorouracil plus folinic acid in colorectal cancer patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/107327480601300105

Chemotherapy permits resection of metastatic colorectal cancer: experience from Intergroup N9741.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/107327480601300105

Hospital volume and surgical mortality in the United States.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/107327480601300105

Radiofrequency ablation of liver metastases from colorectal carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/107327480601300105

Intraoperative radiofrequency ablation or cryoablation for hepatic malignancies

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/107327480601300105

Radiofrequency ablation of unresectable hepatic malignancies: lessons learned

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/107327480601300105

Indicators of recurrence following cryotherapy for hepatic metastases from colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/107327480601300105

Long-term results of treating hepatic colorectal metastases with cryosurgery

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/107327480601300105

Choice of surveillance after hepatectomy for colorectal metastases

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/107327480601300105

Detecting curable disease following hepatectomy for colorectal metastases

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/107327480601300105

Clinical practice. Surveillance strategies after curative treatment of colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/107327480601300105

10.1177/107327480601300105

21 January 2018

Identifiers

DOI

0 references

1 reference